In an early attempt, Woodbury et al. [41] employed an antibody array to detect hepatocyte growth factor (HGF) as a biomarker in the sera collected from breast cancer patients using tyramide signal amplification (TSA). This evidence concerns the gene HGF and breast carcinoma.